While Tango Therapeutics Inc has underperformed by -4.49%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, TNGX rose by 237.22%, with highs and lows ranging from $11.20 to $1.03, whereas the simple moving average jumped by 106.57% in the last 200 days.
On November 18, 2025, Wolfe Research started tracking Tango Therapeutics Inc (NASDAQ: TNGX) recommending Peer Perform. A report published by Piper Sandler on August 19, 2025, Initiated its previous ‘Overweight’ rating for TNGX. Jefferies also rated TNGX shares as ‘Buy’, setting a target price of $19 on the company’s shares in an initiating report dated July 17, 2024. Piper Sandler initiated its ‘Overweight’ rating for TNGX, as published in its report on February 12, 2024. B. Riley Securities’s report from December 08, 2023 suggests a price prediction of $16 for TNGX shares, giving the stock a ‘Buy’ rating. H.C. Wainwright also rated the stock as ‘Buy’.
Analysis of Tango Therapeutics Inc (TNGX)
Further, the quarter-over-quarter increase in sales is 363.61%, showing a positive trend in the upcoming months.
Tango Therapeutics Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -51.65% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 8.88, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and TNGX has an average volume of 3.17M. On a monthly basis, the volatility of the stock is set at 8.57%, whereas on a weekly basis, it is put at 7.17%, with a gain of 3.89% over the past seven days. Furthermore, long-term investors anticipate a median target price of $13.00, showing growth from the present price of $10.42, which can serve as yet another indication of whether TNGX is worth investing in or should be passed over.
How Do You Analyze Tango Therapeutics Inc Shares?
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 34.17%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 72.60% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
